Format

Send to

Choose Destination
See comment in PubMed Commons below
J Altern Complement Med. 2006 Sep;12(7):625-31.

The effect of Johrei healing on substance abuse recovery: a pilot study.

Author information

1
Department of Psychology, University of Arizona, Tucson, AZ 85721, USA. brooksaj@email.arizona.edu

Abstract

OBJECTIVE:

The purpose of the present study was to determine the effectiveness of Johrei healing, a form of energy healing, on substance use and psychologic symptoms in a sample of clients receiving substance abuse treatment.

METHODS:

Twenty-one (21) persons in residential substance-abuse treatment participated in a randomized, wait-list control pilot study of Johrei healing. Twelve (12) of the participants received three 20-minute Johrei sessions for 5 weeks in addition to their regular treatment.

RESULTS:

The results are from the first treatment wave. Individual healing sessions were evaluated pre-post with the Johrei Experience Scale. Participants showed significant decreases in stress/depression and physical pain and increases in positive emotional/spiritual state, energy, and overall well-being after an individual Johrei healing session. The Global Assessment of Individual Need (GAIN), Profile of Mood States (POMS), General Alcoholics Anonymous Tools of Recovery, and 12-Step Participation scales were administered before and after the 5-week intervention to assess change in substance use, psychologic distress, mood, and 12-Step participation. Improvements in depression and trauma symptoms, externalizing behaviors (GAIN), and vigor (POMS) were found for the treatment group. Despite comparable 12-Step attendance the treatment group showed greater improvement than the wait-list control group in the use of 12-Step recovery tools. No difference in substance use was found between the two groups.

CONCLUSIONS:

Variables related to substance use and relapse showed improvement in the treatment group suggesting that Johrei healing shows promise and should be studied with a larger sample, over a longer treatment period, with sham controls.

PMID:
16970532
DOI:
10.1089/acm.2006.12.625
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Mary Ann Liebert, Inc.
    Loading ...
    Support Center